Search Ontology:
ChEBI
ruxolitinib
- Term ID
- CHEBI:66919
- Synonyms
-
- (3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile
- INCB018424
- ruxolitinib
- Definition
- A pyrazole substituted at position 1 by a 2-cyano-1-cyclopentylethyl group and at position 3 by a pyrrolo[2,3-d]pyrimidin-4-yl group. Used as the phosphate salt for the treatment of patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis.
- References
-
- CAS:941678-49-5
- Drug_Central:4190
- KEGG:D09959
- LINCS:LSM-1139
- PMID:21602517
- PMID:21919691
- PMID:21926964
- PMID:22034658
- PMID:22227528
- PMID:22279053
- PMID:22281165
- PMID:22375970
- PMID:22375971
- PMID:22399854
- PMID:22422826
- PMID:22474318
- PMID:22544377
- PMID:22718840
- PMID:22830345
- Patent:US2008312258
- Patent:US2010190981
- Reaxys:18703668
- Wikipedia:Ruxolitinib
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
- inverse has_part
-
Phenotype
Phenotype resulting from ruxolitinib
Phenotype where environments contain ruxolitinib
Phenotype modified by environments containing ruxolitinib
Human Disease / Model Data